Fate Therapeutics Files $300M Shelf Registration and Enters $100M ATM Agreement

Filing content

The company filed a shelf registration for up to $300 million in securities and entered into a sales agreement with Leerink Partners to sell up to $100 million of common stock through an at-the-market offering.